omniture

Hot Stock Research for Pharmasset, Cooper Industries, Central Fund of Canada, Gilead Sciences, Invivo Therapeutics & SINA

2011-11-22 22:14 2403

VANCOUVER, British Columbia, November 22, 2011 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pharmasset (NASDAQ:VRUS), Cooper Industries (NYSE:CBE), Central Fund of Canada (AMEX:CEF), Gilead Sciences (NASDAQ:GILD), Invivo Therapeutics (OTC:NVIV) & SINA (NASDAQ:SINA).

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Pharmasset, Inc. (NASDAQ:VRUS): Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Pharmasset (NASDAQ: VRUS) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell Pharmasset to Gilead Sciences, Inc. in a transaction valued at approximately $11 billion. Insiderslab.com found abnormal trading volume of about 24.37 million shares, which was 16 times of the average volume. The stock price went up 84.59% to $134.14 yesterday. On the same day, the stock price of Gilead Sciences, Inc. (NASDAQ:GILD) dropped 9.08% to $36.26. Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it? Read Full Report: http://www.insiderslab.com/PR3/112211A/VRUS/Pharmasset.pdf

Cooper Industries plc (NYSE:CBE): Cooper lighting expanded its decorative product offering, which was a good news to stock market. In early days, Standard & Poor's said Cooper Industries will replace asset manager Janus Capital Group in the S&P 500 as of the close of trading on November 22. Welcome to join S&P 500. Want to make a killing on this stock? Check out the insider trading here. Read Full Report: http://www.insiderslab.com/PR3/112211A/CBE/CooperIndustries.pdf

Central Fund of Canada Limited (USA) (AMEX:CEF): On Nov 21, Central Fund of Canada (AMEX:CEF) dropped to $21.64 with about 2.71 million shares traded. It is more than double as usual. Do you want to know when company insiders will sell their shares? Want to add and monitor this company on an on-going basis? It can be done for free by registering below. Read Full Report: http://www.insiderslab.com/PR3/112211A/CEF/CentralFundofCanada.pdf

Today Insiderslab.com released other research reports for:

Gilead Sciences, Inc. (NASDAQ:GILD):

Read Full Report: http://www.insiderslab.com/PR3/112211A/GILD/GileadSciences.pdf

Invivo Therapeutics Holdings Corp (OTC:NVIV):

Read Full Report: http://www.insiderslab.com/PR3/112211A/NVIV/InvivoTherapeutics.pdf

SINA Corporation (USA) (NASDAQ:SINA):

Read Full Report: http://www.insiderslab.com/PR3/112211A/SINA/SINA.pdf

More Individual Stock Reports & Sector Reports:
http://www.insiderslab.com/media/

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit http://www.insiderslab.com/disclaimers/disclaimers.php for details.

Source: Insiderslab.com; Insiders.hk
collection